Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lumena Pharmaceuticals Inc.

Division of Shire PLC
www.lumenapharma.com

Latest From Lumena Pharmaceuticals Inc.

Does Shire Have The Strategy To Deliver On Rare Opportunity In Early/Mid Pipeline?

The biotech laid out its pipeline during a Dec. 10 R&D day in hopes of convincing analysts and investors that its rare disease focus will pay off in coming years.

BioPharmaceutical Research and Development Strategies

Shire Tightens R&D Focus, And Decision-Making Criteria

Having winnowed its pipeline and established a tighter focus on rare diseases, Shire will assess each early-stage candidate on the basis of stringent “go/no-go” criteria to rein in R&D spending, Global R&D Chief Phil Vickers said.

BioPharmaceutical Clinical Trials

Shire Tightens R&D Focus, And Decision-Making Criteria

Having winnowed its pipeline and established a tighter focus on rare diseases, Shire will assess each early-stage candidate on the basis of stringent “go/no-go” criteria to rein in R&D spending, Global R&D Chief Phil Vickers said.

BioPharmaceutical Business Strategies

Still Independent, Shire Continues With Goals Modeled On Celgene, Gilead, Biogen Idec

While the proposed merger with AbbVie, abandoned on Oct. 20, took a lot of energy, it did not deter Shire from pursuing its stated strategy, CEO Ornskov tells “The Pink Sheet” DAILY. The specialty firm reported a strong third quarter, with rare disease product sales up 66%.

BioPharmaceutical Ireland
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Shire PLC
  • Senior Management
  • Mike Grey, Pres. & CEO
    Alana B McNulty, CFO
    Alejandro Dorenbaum, MD, CMO
  • Contact Info
  • Lumena Pharmaceuticals Inc.
    Phone: (858) 461-0694
    12531 High Bluff Dr.
    Ste. 110
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register